Search Results

There are 265824 results for: content related to: Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients

  1. You have free access to this content
    Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe and Giovanni FM Strippoli

    Published Online : 8 DEC 2014, DOI: 10.1002/14651858.CD010590.pub2

  2. Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

    Intervention Review

    The Cochrane Library

    Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger and Andreas Engert

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD007303.pub2

  3. Erythropoietin or darbepoetin for patients with cancer

    Intervention Review

    The Cochrane Library

    Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert and Julia Bohlius

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD003407.pub5

  4. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents

    Intervention Review

    The Cochrane Library

    Rahul Mhaskar, Hesborn Wao, Branko Miladinovic, Ambuj Kumar and Benjamin Djulbegovic

    Published Online : 4 FEB 2016, DOI: 10.1002/14651858.CD009624.pub2

  5. 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

    Therapeutic Apheresis and Dialysis

    Volume 14, Issue 3, June 2010, Pages: 240–275, Yoshiharu Tsubakihara, Shinichi Nishi, Takashi Akiba, Hideki Hirakata, Kunitoshi Iseki, Minoru Kubota, Satoru Kuriyama, Yasuhiro Komatsu, Masashi Suzuki, Shigeru Nakai, Motoshi Hattori, Tetsuya Babazono, Makoto Hiramatsu, Hiroyasu Yamamoto, Masami Bessho and Tadao Akizawa

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1744-9987.2010.00836.x

  6. Continued Challenges with the Use of Erythropoiesis-Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy-Guided Health Care

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 5P2, May 2008, Pages: 1S–15S, Ms. Rebecca B. Arbuckle, Ms. Niesha L. Griffith, Dr. Lew M. Iacovelli, Mr. Philip E. Johnson, Mr. James A. Jorgenson, Dr. Dwight D. Kloth, Mr. Charles D. Lucarelli and Mr. Raymond J. Muller

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.5supp.1S

  7. You have free access to this content
    Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 15–25, Juan José Pérez-Ruixo, Mercedes Cucala-Ramos, Ester García-Gonzalo, Beatriz Del Val Romero and Neus Valveny

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04383.x

  8. You have free access to this content
    Erythropoietin and iron therapy in patients with renal failure

    Transfusion Alternatives in Transfusion Medicine

    Volume 11, Issue 1, March 2010, Pages: 20–29, LUCIA DEL VECCHIO and FRANCESCO LOCATELLI

    Version of Record online : 16 OCT 2009, DOI: 10.1111/j.1778-428X.2009.01117.x

  9. You have full text access to this OnlineOpen article
    Pharmacovigilance in practice: erythropoiesis-stimulating agents

    Cancer Medicine

    Volume 3, Issue 5, October 2014, Pages: 1416–1429, Michael Hedenus, Heinz Ludwig, David H. Henry and Eduard Gasal

    Version of Record online : 3 JUN 2014, DOI: 10.1002/cam4.275

  10. Extended administration of erythropoiesis-stimulating agents for optimising the management of renal anaemia: what is the evidence?

    International Journal of Clinical Practice

    Volume 62, Issue 9, August 2008, Pages: 1413–1422, S. D. Roger

    Version of Record online : 7 AUG 2008, DOI: 10.1111/j.1742-1241.2008.01846.x

  11. You have free access to this content
    Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia


    Volume 117, Issue 14, 15 July 2011, Pages: 3268–3275, Alessandra Ferrajoli, Aman U. Buzdar, Yvette DeJesus, Lee Cheng, Laura B. Michaud and Maria A. Rodriguez

    Version of Record online : 24 JAN 2011, DOI: 10.1002/cncr.25865

  12. Effect of Medicare Dialysis Payment Reform on Use of Erythropoiesis Stimulating Agents

    Health Services Research

    Volume 50, Issue 3, June 2015, Pages: 790–808, Shailender Swaminathan, Vincent Mor, Rajnish Mehrotra and Amal N. Trivedi

    Version of Record online : 30 OCT 2014, DOI: 10.1111/1475-6773.12252

  13. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients

    Intervention Review

    The Cochrane Library

    Katherine Ngo, Dipak Kotecha, Julia AE Walters, Luis Manzano, Alberto Palazzuoli, Dirk J van Veldhuisen and Marcus Flather

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD007613.pub2

  14. Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin


    Volume 49, Issue 5, May 2009, Pages: 895–902, Francis Vekeman, Brahim K. Bookhart, Joshua White, R. Scott McKenzie, Mei Sheng Duh, Catherine Tak Piech and Patrick Lefebvre

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1537-2995.2008.02072.x

  15. Erythropoiesis-stimulating agents: friends or foes?


    Volume 53, Issue 9, September 2013, Pages: 1867–1872, Aryeh Shander, Sherri Ozawa, Irwin Gross and David Henry

    Version of Record online : 9 SEP 2013, DOI: 10.1111/trf.12328

  16. You have free access to this content
    Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia

    Hemodialysis International

    Volume 18, Issue 4, October 2014, Pages: 740–750, Sandawana William Majoni, Joy-Anne Ellis, Heather Hall, Asanga Abeyaratne and Paul D. Lawton

    Version of Record online : 27 APR 2014, DOI: 10.1111/hdi.12173


    Journal of Renal Care

    Volume 38, Issue 4, December 2012, Pages: 191–201, Josephine Sau Fan Chow, Glenda Rayment, Veronica Britos, Bruce Cleland and Michael Suranyi

    Version of Record online : 25 AUG 2012, DOI: 10.1111/j.1755-6686.2012.00318.x

  18. Risk evaluation mitigation strategy: impact of application of the Food and Drug Adminstration's strategy on use of erythropoiesis-stimulating agents and transfusion in patients with chemotherapy-induced anaemia

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 3, June 2015, Pages: 299–303, K. Hollingsworth, M. C. Romney, A. Crawford and J. McAna

    Version of Record online : 20 APR 2015, DOI: 10.1111/jcpt.12269

  19. You have free access to this content
    Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives

    British Journal of Haematology

    Volume 146, Issue 2, July 2009, Pages: 127–141, Francesca Merchionne and Franco Dammacco

    Version of Record online : 17 APR 2009, DOI: 10.1111/j.1365-2141.2009.07702.x

  20. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: A time and motion study

    Hemodialysis International

    Volume 12, Issue 4, October 2008, Pages: 441–449, Brigitte SCHILLER, Sheila DOSS, Erwin DE COCK, Michael A. DEL AGUILA and Allen R. NISSENSON

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1542-4758.2008.00308.x